Iterum Therapeutics PLC
NASDAQ:ITRM
Iterum Therapeutics PLC
Selling, General & Administrative
Iterum Therapeutics PLC
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
Selling, General & Administrative
-$7.5m
|
CAGR 3-Years
12%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Perrigo Company PLC
NYSE:PRGO
|
Selling, General & Administrative
-$1.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-8%
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Selling, General & Administrative
-$1.4B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-15%
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Selling, General & Administrative
-$151.7m
|
CAGR 3-Years
-67%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-28%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Selling, General & Administrative
-$11.1m
|
CAGR 3-Years
-366%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Selling, General & Administrative
-€27.8m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-14%
|
See Also
What is Iterum Therapeutics PLC's Selling, General & Administrative?
Selling, General & Administrative
-7.5m
USD
Based on the financial report for Dec 31, 2023, Iterum Therapeutics PLC's Selling, General & Administrative amounts to -7.5m USD.
What is Iterum Therapeutics PLC's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
3%
Over the last year, the Selling, General & Administrative growth was 41%. The average annual Selling, General & Administrative growth rates for Iterum Therapeutics PLC have been 12% over the past three years , 3% over the past five years .